Review article
Molecular detection methods of mutations in the kinase domain of fusion gene bcr-abl1 in patients with chronic myelocyte leukemia
Michaela Bezecná, Ľubica Majerová, Renata Lukačková
The implementation of the treatment with tyrosine kinase inhibitors (TKIs) in patients with chronic myelocyte leukemia has significantly influenced the prognosis of the disease. TKI...
Keywords: mutations in the Abl1 kinase domain, next generation sequencing (NGS), Sanger sequencing
newsLab 2020, 1 : 37-40
